您的位置:网站名称 → 研发专利新闻 → 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit


Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading integrated global pharmaceutical company, today confirmed that it has received a favorable decision from the U.S. Court of Appeals for the Federal Circuit related to its ongoing...

查看所有的文章内容需要 VIP会员权限 查看


 
点这里复制本页地址发送给您QQ/MSN上的好友

相关文章

• US District Court rules against Watson i
• USPTO issues Notice of Allowance to Alph
• VARI, Gentel Biosciences receive U.S. Pa
• Colorcon announces specific details on i
• ACT to be awarded broad patent protectio
• NephRx receives new U.S. patent for NX00
• USPTO grants patent to ULURU's Altrazeal
• NephRx receives new U.S. patent for NX00
• PRWP receives two new patents for Galect
• POZEN files motion for Treximet patent l
• Biotectix acquires Chameleon BioSurfaces
• USPTO issues Notice of Allowance to Modu
• USPTO issues patent to Somaxon's Silenor
• USPTO grants composition-of-matter paten
• USPTO issues patent to Asterand's BioMAP
• Medical industry veteran set to play key
• Cubist enters license agreement with Tev
• Shire files lawsuit against Watson over
• USPTO issues notice of allowance to Mirn
• EPO Board of Appeal rejects B.Braun pate

相关评论


本文章所属分类:首页 → 研发专利新闻